Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Chitosan-based nanoparticles with damnacanthal suppress CRM1 expression.

Chaichanasak N, Rojanapanthu P, Yoon Y, Gritsanapan W, Chirachanchai S, Sathirakul K, Nualsanit T, Seong JK, Baek SJ.

Oncol Lett. 2018 Dec;16(6):7029-7034. doi: 10.3892/ol.2018.9507. Epub 2018 Sep 26.

2.

Self-assembled nanomicelles of damnacanthal-loaded amphiphilic modified chitosan: Preparation, characterization and cytotoxicity study.

Sukamporn P, Baek SJ, Gritsanapan W, Chirachanchai S, Nualsanit T, Rojanapanthu P.

Mater Sci Eng C Mater Biol Appl. 2017 Aug 1;77:1068-1077. doi: 10.1016/j.msec.2017.03.263. Epub 2017 Apr 5.

PMID:
28531980
3.

Damnacanthal-induced anti-inflammation is associated with inhibition of NF-κB activity.

Nualsanit T, Rojanapanthu P, Gritsanapan W, Kwankitpraniti T, Min KW, Baek SJ.

Inflamm Allergy Drug Targets. 2011 Dec;10(6):455-63.

PMID:
21999179
4.

Damnacanthal, a noni component, exhibits antitumorigenic activity in human colorectal cancer cells.

Nualsanit T, Rojanapanthu P, Gritsanapan W, Lee SH, Lawson D, Baek SJ.

J Nutr Biochem. 2012 Aug;23(8):915-23. doi: 10.1016/j.jnutbio.2011.04.017. Epub 2011 Aug 17.

5.

Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53.

Zhong Y, Krisanapun C, Lee SH, Nualsanit T, Sams C, Peungvicha P, Baek SJ.

Eur J Cancer. 2010 Dec;46(18):3365-74. doi: 10.1016/j.ejca.2010.07.007. Epub 2010 Aug 13.

Supplemental Content

Loading ...
Support Center